Meredith Brown-Tuttle

Executive Director, Regulatory Affairs @Crinetics Pharmaceuticals

San Jose, CA, US
EMAILS
m••••••••@crinetics.com
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Executive Director, Regulatory Affairs @Crinetics Pharmaceuticals

View department →

San Diego, CA, US

EDUCATION

1996

San José State University

BA, Neuroscience

1999 — 2000

University of California, Santa Cruz

Clinical Trials Design and Management

SKILLS

Regulatory ResearchRegulatory AffairsFdaIndRegulatory SubmissionsRegulatory IntelligenceMarketing ApplicationsNdaClinical TrialsArticlesClinical DevelopmentGcpBiotechnologyPharmaceutical IndustryDrug DevelopmentEctdOncologyMedical WritingRegulatory RequirementsSopMedical DevicesClinical ResearchBiopharmaceuticalsMaaInfectious DiseasesProtocolElectronic SubmissionsBiologicsRegulatory DocumentationClinical Study DesignNeuroscienceClinical Data ManagementRegulatory GuidelinesIch-GcpRegulationsCROPharmacovigilanceLife SciencesCRO ManagementGood Clinical Practice (Gcp)

ABOUT MEREDITH BROWN-TUTTLE

Global Regulatory Affairs experience in 42+ countries including:Strategy and Intelligence: Created and managed global Regulatory Strategy for drugs, devices and combination productsConducted Regulatory Research and Intelligence on a global scale for various therapeutic indicationsPerformed strategic gap analyses to identify potential issues to successful IND, NDA, MAA and BLA filingsSubmissions:INDs, CTAs, IMPDs, NDA, MAA, Orphan Drug Designations (EU & US), PIP, PSP, Fast Track Designation requests, QIDP, trade name requests, DSUR, 510(k), PMA, PSUR,+ amendmentsAgency Interactions:US, Canada, EU, India, Australia, Africa and Eastern EuropeMarketing Applications Written/Planned/Submitted: 505(b)(1), 505(b)(2) and hybrid: New Drug Application (NDA) and Marketing Authorization Application (MAA) Meetings:Wrote and compiled associated packages for both FDA, Health Canada, EMA and EU agency meetingsConducted in-person or teleconferences with the FDA and EMA Countries:Wrote and coordinated regulatory submissions for: United States, Australia, Canada, Eastern Europe, Europe, Israel, India, Latin America, Middle East, Singapore, South Africa and South America.Commercial Product Experience:•Wrote, reviewed and approved labeling (package inserts, carton, vials) for US and EU drug and device products•Reviewed promotional materials (press releases, web sites, advertising/marketing materials, call center scripts)•Reviewed State regulatory requirements for commercial product distribution and licensing•Assisted with Establishment & Drug Listing and NDC number registrationPublished \"IND Submissions: A Primer,\" Regulatory Intelligence, regulatory strategy, regulatory research,global regulatory submissions, writing and compiling submissions, protocols and investigator\'s brochures

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Meredith Brown-Tuttle — Email, Phone Number & Contact Info | Unifers